1. Home
  2. SNDX vs DGII Comparison

SNDX vs DGII Comparison

Compare SNDX & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
    SELLHOLDBUYas of a day ago
  • DGII
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • SNDX 2005
  • DGII 1985
  • Country
  • SNDX United States
  • DGII United States
  • Employees
  • SNDX N/A
  • DGII N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • DGII Computer peripheral equipment
  • Sector
  • SNDX Health Care
  • DGII Technology
  • Exchange
  • SNDX Nasdaq
  • DGII Nasdaq
  • Market Cap
  • SNDX 1.4B
  • DGII 1.2B
  • IPO Year
  • SNDX 2016
  • DGII N/A
  • Fundamental
  • Price
  • SNDX $13.08
  • DGII $31.25
  • Analyst Decision
  • SNDX Strong Buy
  • DGII Buy
  • Analyst Count
  • SNDX 11
  • DGII 5
  • Target Price
  • SNDX $37.64
  • DGII $34.80
  • AVG Volume (30 Days)
  • SNDX 2.0M
  • DGII 237.3K
  • Earning Date
  • SNDX 11-05-2024
  • DGII 01-29-2025
  • Dividend Yield
  • SNDX N/A
  • DGII N/A
  • EPS Growth
  • SNDX N/A
  • DGII N/A
  • EPS
  • SNDX N/A
  • DGII 0.61
  • Revenue
  • SNDX $16,000,000.00
  • DGII $424,046,000.00
  • Revenue This Year
  • SNDX N/A
  • DGII $3.19
  • Revenue Next Year
  • SNDX N/A
  • DGII $5.56
  • P/E Ratio
  • SNDX N/A
  • DGII $50.77
  • Revenue Growth
  • SNDX N/A
  • DGII N/A
  • 52 Week Low
  • SNDX $12.76
  • DGII $20.17
  • 52 Week High
  • SNDX $25.34
  • DGII $34.82
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 28.91
  • DGII 48.68
  • Support Level
  • SNDX $13.26
  • DGII $31.29
  • Resistance Level
  • SNDX $14.18
  • DGII $33.78
  • Average True Range (ATR)
  • SNDX 0.83
  • DGII 1.05
  • MACD
  • SNDX -0.18
  • DGII -0.22
  • Stochastic Oscillator
  • SNDX 7.08
  • DGII 27.20

Stock Price Comparison Chart: SNDX vs DGII

SNDX
DGII
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober051015202530354045SNDX VS DGII

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use